Correlation Between Scopus Biopharma and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Akari Therapeutics PLC, you can compare the effects of market volatilities on Scopus Biopharma and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Akari Therapeutics.
Diversification Opportunities for Scopus Biopharma and Akari Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scopus and Akari is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Scopus Biopharma and Akari Therapeutics
If you would invest (100.00) in Scopus Biopharma on December 2, 2024 and sell it today you would earn a total of 100.00 from holding Scopus Biopharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Scopus Biopharma vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Akari Therapeutics PLC |
Scopus Biopharma and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and Akari Therapeutics
The main advantage of trading using opposite Scopus Biopharma and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Scopus Biopharma vs. Scpharmaceuticals | ||
| Scopus Biopharma vs. DiaMedica Therapeutics | ||
| Scopus Biopharma vs. Monopar Therapeutics | ||
| Scopus Biopharma vs. Pasithea Therapeutics Corp |
| Akari Therapeutics vs. Armata Pharmaceuticals | ||
| Akari Therapeutics vs. Anebulo Pharmaceuticals | ||
| Akari Therapeutics vs. Processa Pharmaceuticals | ||
| Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |